Profil
Mark L.
Lewis is currently the Executive Chairman at Miroculus, Inc. He previously worked as the Director at Swift Biosciences, Inc. from 2017 to 2021.
He also held the position of General Manager & Vice President at BD Biosciences Clontech.
Aktive Positionen von Mark L. Lewis
| Unternehmen | Position | Beginn |
|---|---|---|
Miroculus, Inc.
 Miroculus, Inc. Packaged SoftwareTechnology Services Miroculus, Inc. operates as a biotechnology company specializing in microRNA-based diagnostics. It offers a non-invasive microRNA detection platform for molecular data gathering, analysis, and interpretation applications. The company was founded by Alejandro Tocigl Domeyko, Jorge Soto and Fay Christodoulou and is headquartered in San Francisco, CA. | Vorsitzender | 19.04.2022 |
Ehemalige bekannte Positionen von Mark L. Lewis
| Unternehmen | Position | Ende |
|---|---|---|
Swift Biosciences, Inc.
 Swift Biosciences, Inc. BiotechnologyHealth Technology Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI. | Vorstandsvorsitzender | 01.01.2018 |
BD Biosciences Clontech
 BD Biosciences Clontech BiotechnologyHealth Technology BD Biosciences Clontech develops, produces, and markets biological products to the life science market worldwide. The firm produces biological systems, kits and support products for use in fields such as drug discovery, cancer research, neurobiology, pharmacology, cell biology and functional genomics. The company is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology BD Biosciences Clontech develops, produces, and markets biological products to the life science market worldwide. The firm produces biological systems, kits and support products for use in fields such as drug discovery, cancer research, neurobiology, pharmacology, cell biology and functional genomics. The company is headquartered in Palo Alto, CA. | Health Technology |
Miroculus, Inc.
Miroculus, Inc. Packaged SoftwareTechnology Services Miroculus, Inc. operates as a biotechnology company specializing in microRNA-based diagnostics. It offers a non-invasive microRNA detection platform for molecular data gathering, analysis, and interpretation applications. The company was founded by Alejandro Tocigl Domeyko, Jorge Soto and Fay Christodoulou and is headquartered in San Francisco, CA. | Technology Services |
Swift Biosciences, Inc.
Swift Biosciences, Inc. BiotechnologyHealth Technology Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI. | Health Technology |